Regulatory Genome Development
RegGenome’s vision is to transform the way the world consumes regulatory information.
Regulatory Genome Development has raised €5.5M across 1 funding round from 4 investors, most recently a Seed round in Apr 2022. Based in Cambridge, UK; active in Software. Data as of 28 Oct 2026.
Cambridge, UKwww.regulatorygenome.org ↗
Total raised
€5.5M
€5,511,953
Funding rounds
1
Investors
4
distinct backers
Active since
2022-04
latest 2022-04
Funding by year
EUR raised per yearRegulatory Genome Development — funding by year — interactive chart.
Data table
| Regulatory Genome Development — funding by year | |
|---|---|
| 2022 | €5.5M |
Signals
High confidenceRaise-next likelihood8
base rate 44% for Seed
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-04-12 | Seed | €5.5M | AlbionVC,Cambridge Enterprise,Evolution Equity Partners,Mastercard | View deal → |
Related news
- Mastercard joins Cambridge Uni spinout’s £4.6m seed roundbusinesscloud.co.uk · 2022-04
Similar companies
same sector or countryGlobal coverage: FundingData